By Kwok Chow, PhD, and Anil Kane, PhD
Improving the bioavailability of poorly soluble new chemical entities is a leading challenge in drug development.
Parallel screening is a cost-effective concept for selecting a suitable drug delivery system to enhance the chance of achieving the bioavailability target in the clinic.
Download to find out more.
By downloading this whitepaper, you acknowledge that Global Data UK Limited may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.